Latest News and Press Releases
Want to stay updated on the latest news?
-
Ad hoc-Mitteilung gemäss Art. 53 KR Allschwil, 25. Februar 2026 Basilea Pharmaceutica AG, Allschwil (SIX: BSLN), ein biopharmazeutisches Unternehmen mit bereits vermarkteten Produkten und...
-
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, February 25, 2026 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company...
-
CERRITOS, CA , Feb. 24, 2026 (GLOBE NEWSWIRE) -- Health Mate continues to advance the home wellness space with premium infrared sauna systems engineered for powerful, even heat and maximum comfort....
-
Not for distribution to U.S. news wire services or dissemination in the United States. The base shelf prospectus is accessible, and the shelf prospectus supplement for this offering will be...
-
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES TORONTO, Feb. ...
-
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers. ...
-
NEW YORK, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Ashford Hospitality Trust, Inc. (“Ashford” or the “Company”) (NYSE: AHT). Such investors...
-
Útgerðarfélag Reykjavíkur hf. (ÚR) hélt lokað útboð á á nýjum 6 mánaða víxlaflokki UR 26 0901. ÚR hefur ákveðið að taka tilboðum að fjárhæð 1.000 m.kr. með 7,96% vöxtum, sem samsvarar 0,39% álagi á 6M...
-
Investors who lost money in GEMI after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
-
Net Income per Diluted Share of $0.99 for the Fourth Quarter and $10.84 for the Full Year of 2025 Core FFO per Share of $1.40 for the Fourth Quarter and $6.68 for the Full Year of 2025 ...